let's wait and see how would the annual report do to this stock in July
On the webinar, JK said AT1 has already close to double its revenue (30/4) compare to FY19 and this does not include anything related to COVID-19. AT1 has already sold 1.3 million devices to NG till now and many more to come.
If AT1 gets a deal with a US company,(JK said he's in discussion with 2 US companies) that would be huge, given there's already FDA approval for the COVID antibody test to another company.
AT1 Charts, page-107
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.10M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $1.244K | 61.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1627919 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 152000 | 2 |
View Market Depth
| Last trade - 15.45pm 09/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |